Skip to main content
Have a personal or library account? Click to login
Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling Cover

Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling

International Journal of Applied Mathematics and Computer Science
Volume 18 (2008): Issue 3 (September 2008)
By:   
Open Access
|Oct 2008
References

References

  1. Adam J. and N. Bellomo E. (1997)., Birkhäuser, Boston, MA.
    Open DOISearch in Google Scholar
  2. Banerjee S. and Sarkar R. R. (2008). Delay induced model for tumor-immune interaction and control of malignant tumor growth,(1): 268-288.
    Open DOISearch in Google Scholar
  3. Bodnar M. and Foryś U. (2000a). Behaviour of solutions to Marchuk's model depending on a time delay,(1): 97-112.
    Search in Google Scholar
  4. Bodnar M. and Foryś U. (2000b). Periodic dynamics in the model of immune system,(1): 113-126.
    Open DOISearch in Google Scholar
  5. Bodnar M. and Foryś U. (2003a). Time delays in proliferation process for solid avascular tumor,(11): 1201-1209.
    Open DOISearch in Google Scholar
  6. Bodnar M. and Foryś U. (2003b). Time delays in regulatory apoptosis for solid avascular tumor,(11): 1211-1220.
    Open DOISearch in Google Scholar
  7. Byrne H. M. (1997). The effect of time delays on the dynamics of avascular tumor growth,(2): 83-117.
    Open DOISearch in Google Scholar
  8. Curti B. D., Ochoa A. C., Urba W. J., Alvord W. G., Kopp W. C., Powers G., Hawk C., Creekmore S. P., Gause B. L., Janik J. E., Holmlund J. T., Kremers P., Fenton R. G., Miller L., Sznol M., II J. W. S., Sharfman W. H. and Longo D. L. (1996). Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti3-stimulatedcells: Results from a phasetrial in cancer patients,(4): 296-308.
    Open DOISearch in Google Scholar
  9. Foryś U. (2002). Marchuk's model of immune system dynamics with application to tumor growth,(1): 85-93.
    Open DOISearch in Google Scholar
  10. Freedman H. I., Erbe L. and Rao V. S. H. (1986). Three species food chain models with mutual interference and time delays,(1): 57-80.
    Open DOISearch in Google Scholar
  11. Freedman H. I. and Rao V. S. H. (1983). The trade-off between mutual interference and time lags in predator-prey systems,(6): 991-1004.
    Open DOISearch in Google Scholar
  12. Galach M. (2003). Dynamics of the tumor-immune system competition-the effect of time delay,(3): 395-406.
    Search in Google Scholar
  13. Gause B. L., Sznol M., Kopp W. C., Janik J. E., II J. W. S., Steis R. G., Urba W. J., Sharfman W., Fenton R. G., Creekmore S. P., Holmlund J., Conlon K. C., VanderMolen L. A. and Longo D. L. (1996). Phasestudy of subcutaneously administered interleuking-2 in combination with interferon alfa-2a in patients with advanced cancer,(8): 2234-2241.
    Open DOISearch in Google Scholar
  14. Hale J. and Lunel S. (1993)., Springer-Verlag, New York, NY.
    Open DOISearch in Google Scholar
  15. Hara I., Hotta H., Sato N., Eto H., Arakawa S. and Kamidono S. (1996). Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2,(7): 724-729.
    Open DOISearch in Google Scholar
  16. Kaempfer R., Gerez L., Farbstein H., Madar L., Hirschman O., Nussinovich R. and Shapiro A. (1996). Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression,(6): 1778-1786.
    Open DOISearch in Google Scholar
  17. Keilholz U., Scheibenbogen C., Stoelben E., Saeger H. D. and Hunstein W. (1994). Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions,(7): 955-958.
    Open DOISearch in Google Scholar
  18. Kirschner D. and Panetta J. C. (1998). Modeling immunotherapy of the tumor — immune interaction,(3): 235-252.
    Open DOISearch in Google Scholar
  19. Kolev M. (2003). Mathematical modeling of the competition between acquired immunity and cancer,(3): 289-296.
    Search in Google Scholar
  20. Kuznetsov V. A., Makalkin I. A., Taylor M. A. and Perelson A. S. (1994). Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis,(2): 295-321.
    Open DOISearch in Google Scholar
  21. Matzavinos A., A. J. Chaplain M. and Kuznetsov V. A. (2004). Mathematical modelling of the spatio-temporal response of cytotoxic-lymphocytes to a solid tumor,(1): 1-34.
    Open DOISearch in Google Scholar
  22. Rabinowich H., Banks M., Reichert T. E., Logan T. F., Kirkwood J. M. and Whiteside T. L. (1996). Expression and activity of signaling molecules in-lymphocytes obtained from patients with metastatic melanoma before and after interleukin-2 therapy,(8): 1263-1274.
    Search in Google Scholar
  23. Rosenberg S. A. and Lotze M. T. (1986). Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes,(1): 681-709.
    Open DOISearch in Google Scholar
  24. Rosenberg S. A., Yang J. C., Topalian S. L., Schwartzentruber D. J., Weber J. S., Parkinson D. R., Seipp C. A., Einhorn J. H. and White D. E. (1994). Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2,(12): 907-913.
    Open DOISearch in Google Scholar
  25. Rosenstein M., Ettinghousen S. E. and Rosenberg S. A. (1986). Extravasion of intravascular fluid mediated by the systemic administration of recombinant interleukin-2,(5): 1735-1742.
    Open DOISearch in Google Scholar
  26. Sarkar R. R. and Banerjee S. (2005). Cancer self remission and tumor stability — A stochastic approach,(1): 65-81.
    Open DOISearch in Google Scholar
  27. Schwartzentruber D. J. (1993). In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy,(6): 1055-1058.
    Open DOISearch in Google Scholar
  28. Szymańska Z. (2003). Analysis of immunotherapy models in the context of cancer dynamics,(3): 407-418.
    Search in Google Scholar
  29. Tartour E., Blay J. Y., Dorval T., Escudier B., Mosseri V., Douillard J. Y., Deneux L., Gorin I., Negrier S., Mathio C., Pouillart P. and Fridman W. H. (1996). Predictors of clinical response to interleukin-2-based immunotherapy in melanoma patients: A French multi-institutional study,(5): 1697-1703.
    Open DOISearch in Google Scholar
  30. Yang X., Chen L. and Chen J. (1996). Permanence and positive periodic solution for the single-species nonautonomous delay diffusive model,(4): 109-116.
    Open DOISearch in Google Scholar
  31. Zhivkovc P. and Waniewski J. (2003). Modeling tumor-immunity interactions with different stimulation functions,(3): 307-315.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10006-008-0035-6 | Journal eISSN: 2083-8492 | Journal ISSN: 1641-876X
Journal RSS Feed
Language: English
Page range: 389 - 398
Published on: Oct 6, 2008
Published by: University of Zielona Góra
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
effector cells,
tumor cells,
interleukin-2,
discrete time delay
Related subjects:
Mathematics,
Applied mathematics

© 2008 Sandip Banerjee, published by University of Zielona Góra
This work is licensed under the Creative Commons License.

Volume 18 (2008): Issue 3 (September 2008)
Previous article
Next article